Last reviewed · How we verify
NCT04151966
Myocardial Injury Following Elective Direct Current Cardioversion for Atrial Arrhythmias
trial testing Blood sample collection in Cardioversion in 104 participants. Completed in 1 December 2021.
5 June 2020
Quick facts
| Lead sponsor | Mayo Clinic |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 104 |
| Start date | 22 July 2019 |
| Primary completion | 5 June 2020 |
| Estimated completion | 1 December 2021 |
| Sites | 1 location across United States |
Drugs / interventions tested
- Blood sample collection — full drug profile →
Conditions studied
- Cardioversion — all drugs for Cardioversion →
Sponsor
Mayo Clinic
Who can join
18 and older, any sex, with Cardioversion. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Researchers are trying to determine if heart injury occurs in subjects who undergo direct current cardioversion.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Absence of significant myocardial injury following elective direct current cardioversion for atrial fibrillation.
Lobo R, White RD, Donato LJ, Wockenfus AM, et al · · 2023 · cited 5× · PMID 36993913 · DOI 10.1016/j.hroo.2022.12.004
Verify or expand the search:
- PubMed search for NCT04151966
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Blood sample collection
Trials testing the same drug.
- NCT07243067 — Tumor-Derived Extracellular Vesicles for Noninvasive Molecular Classification of Kidney Cancer · not yet recruiting
- NCT07499921 — Clinical and BIOgical Analyses of RECtal Tumors · NA · not yet recruiting
- NCT07516392 — Study of a Polygenic Risk Score to Predict the Risk of Pancreatic Ductal Adenocarcinoma · NA · not yet recruiting
- NCT07455136 — A Study to Develop a Blood-based Test for Aiding the Diagnosis/Prognosis of Traumatic Brain Injury in Adults and for Mon · recruiting
- NCT07063719 — Identification of Cellular Biomarkers of Rare Eye Diseases in Adults · NA · not yet recruiting
Other recruiting trials for Cardioversion
Currently open trials in the same condition.
- NCT06556667 — MAX - SHOCK Clinical Trial · NA · recruiting
Other Mayo Clinic trials
Trials by the same sponsor.
- NCT07126548 — A Point of Prostate Cancer Diagnosis Virtual Reality Assistant Intervention in Supporting Newly Diagnosed Black Men · NA · not yet recruiting
- NCT07221656 — Evaluation of Prolonged Asparaginase Activity Levels After Calaspargase Pegol Administration · not yet recruiting
- NCT06891001 — The Utilization of a Shoe Insert on Individuals With Unilateral Greater Trochanteric Pain Syndrome on Single Leg Stance, · NA · not yet recruiting
- NCT07169799 — Impact of Cryotherapy Spray (Tru-Freeze) for the Eradication of Gastric Antral Vascular Ectasia (ICE-GAVE) · NA · recruiting
- NCT07086183 — Perioperative Risk in Patients on Chronic Aspirin Undergoing Craniotomy · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04151966 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Mayo Clinic
- Last refreshed: 5 January 2022
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04151966.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing